Stock data
Sutro Biopharma, Inc. (STRO)
Sutro Biopharma, Inc. (STRO) reported revenue of US$102.48M and net income of -US$191.09M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$102.48M | — | -US$158.37M | -US$191.09M | — |
| 2024 | US$62.04M | — | -US$238.45M | -US$227.46M | — |
| 2023 | US$153.73M | — | -US$89.28M | -US$106.79M | — |
| 2022 | US$67.77M | — | -US$128.94M | -US$119.20M | — |
| 2021 | US$61.88M | — | -US$98.52M | -US$105.54M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$9.84M | -US$38.53M | — |
| 2026-03-31 | US$14.52M | -US$38.48M | — |
| 2025-12-31 | US$11.65M | -US$46.76M | — |
| 2025-09-30 | US$9.69M | -US$56.86M | — |
| 2025-06-30 | US$63.74M | -US$11.50M | — |
| 2025-03-31 | US$17.40M | -US$75.97M | — |
| 2024-12-31 | US$14.81M | -US$72.44M | — |
| 2024-09-30 | US$8.52M | -US$48.79M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.